<DOC>
	<DOCNO>NCT00329576</DOCNO>
	<brief_summary>To evaluate persistence antibody hepatitis B , approximately 5 6 year first dose hepatitis B primary vaccination study .</brief_summary>
	<brief_title>Evaluate Immune Response Approximately 5 6 Years After Receiving Different Formulations GSK Bio Hep B Vaccine</brief_title>
	<detailed_description>All subject participate primary vaccination study , subject receive GSK Biologicals ' hepatitis B vaccine consent participate long-term follow-up study , approximately 5 6 year primary vaccination study . The study conduct 3 centre 4 centre primary vaccination study .</detailed_description>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects participate primary study receive first primary dose vaccination five year ago less six year ago blood sample longterm followup study . Written inform consent obtain subject longterm followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>